Cowen downgraded Graphite Bio to Market Perform from Outperform without a price target.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on GRPH:
- Graphite Bio to explore strategic alternatives, cuts staff by 50%
- Graphite Bio downgraded to Neutral from Buy at BTIG
- Graphite Bio downgraded to Neutral from Buy at BofA
- Graphite Bio price target lowered to $4 from $11 at RBC Capital
- Graphite Bio downgraded to Market Perform from Outperform at SVB Securities